Journal article
Nanotechnology in the management of cervical cancer
Reviews in Medical Virology, Vol.25(Supplement 1), pp.72-83
2015
Abstract
Cervical cancer is a major disease with high mortality. All cervical cancers are caused by infection with human papillomaviruses (HPV). Although preventive vaccines for cervical cancer are successful, treatment of cervical cancer is far less satisfactory because of multidrug resistance and side effects. In this review, we summarize the recent application of nanotechnology to the diagnosis and treatment of cervical cancer as well as the development of HPV vaccines. Early detection of cervical cancer enables tumours to be efficiently removed by surgical procedures, leading to increased survival rate. The current method of detecting cervical cancer by Pap smear can only achieve 50% sensitivity, whereas nanotechnology has been used to detect HPVs with greatly improved sensitivity. In cervical cancer treatment, nanotechnology has been used for the delivery of anticancer drugs to increase treatment efficacy and decrease side effects. Nanodelivery of HPV preventive and therapeutic vaccines has also been investigated to increase vaccine efficacy. Overall, these developments suggest that nanoparticle-based vaccine may become the most effective way to prevent and treat cervical cancer, assisted or combined with some other nanotechnology-based therapy. Copyright © 2015 John Wiley & Sons, Ltd.
Details
- Title
- Nanotechnology in the management of cervical cancer
- Authors
- Jiezhong Chen (Author) - University of QueenslandWenyi Gu (Author) - University of QueenslandLei Yang (Author) - Hangzhou Normal University, ChinaChen Chen (Author) - University of QueenslandRenfu Shao (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and EngineeringKewei Xu (Author) - University of QueenslandZhi Ping Xu (Author) - University of Queensland
- Publication details
- Reviews in Medical Virology, Vol.25(Supplement 1), pp.72-83
- Publisher
- John Wiley & Sons Ltd.
- Date published
- 2015
- DOI
- 10.1002/rmv.1825
- ISSN
- 1052-9276
- Organisation Unit
- School of Science and Engineering - Legacy; University of the Sunshine Coast, Queensland; School of Science, Technology and Engineering; Centre for Bioinnovation
- Language
- English
- Record Identifier
- 99450183402621
- Output Type
- Journal article
Metrics
16 File views/ downloads
917 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Virology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites